# Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome

> **NCT07276568** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Zhi-Jun Zhu** · enrollment: 12 (estimated)

## Conditions studied

- Small-for-size Syndrome

## Interventions

- **DRUG:** Hepatocyte-like cell administration via rectus sheath intramuscular injection

## Key facts

- **NCT ID:** NCT07276568
- **Lead sponsor:** Zhi-Jun Zhu
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-17
- **Primary completion:** 2028-12-01
- **Final completion:** 2029-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276568, "Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07276568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*